Veronique Preat

Veronique Preat

Université Catholique de Louvain

H-index: 89

Europe-Belgium

About Veronique Preat

Veronique Preat, With an exceptional h-index of 89 and a recent h-index of 60 (since 2020), a distinguished researcher at Université Catholique de Louvain, specializes in the field of Drug delivery, nanomedicines.

His recent articles reflect a diverse array of research interests and contributions to the field:

In situ administration of STING-activating hyaluronic acid conjugate primes anti-glioblastoma immune response

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

Multifunctional self-assembled peptide hydrogels for biomedical applications

Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma

Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI

Local delivery of doxorubicin prodrug via lipid nanocapsule–based hydrogel for the treatment of glioblastoma

Combination of local immunogenic cell death-inducing chemotherapy and DNA vaccine increases the survival of glioblastoma-bearing mice

Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel

Veronique Preat Information

University

Université Catholique de Louvain

Position

Professeur

Citations(all)

34305

Citations(since 2020)

14677

Cited By

25746

hIndex(all)

89

hIndex(since 2020)

60

i10Index(all)

280

i10Index(since 2020)

187

Email

University Profile Page

Université Catholique de Louvain

Veronique Preat Skills & Research Interests

Drug delivery

nanomedicines

Top articles of Veronique Preat

Title

Journal

Author(s)

Publication Date

In situ administration of STING-activating hyaluronic acid conjugate primes anti-glioblastoma immune response

Materials Today Bio

Teenesha Chellen

Mathilde Bausart

Pierre Maus

Kevin Vanvarenberg

Nisha Limaye

...

2024/4/16

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

Advanced Functional Materials

Carina Peres

Ana I Matos

Bárbara Carreira

Liane IF Moura

Ron Kleiner

...

2024/4/1

Multifunctional self-assembled peptide hydrogels for biomedical applications

Mahsa Sedighi

Neha Shrestha

Zahra Mahmoudi

Zahra Khademi

Alireza Ghasempour

...

2023/1

Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma

International Journal of Pharmaceutics: X

Mingchao Wang

Alessio Malfanti

Chiara Bastiancich

Véronique Préat

2023/12/1

Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI

Biomedicines

Jérôme Conq

Nicolas Joudiou

Bernard Ucakar

Kevin Vanvarenberg

Véronique Préat

...

2023/7/11

Local delivery of doxorubicin prodrug via lipid nanocapsule–based hydrogel for the treatment of glioblastoma

Drug delivery and translational research

Mingchao Wang

Raphaël Bergès

Alessio Malfanti

Véronique Préat

Chiara Bastiancich

2023/10/27

Combination of local immunogenic cell death-inducing chemotherapy and DNA vaccine increases the survival of glioblastoma-bearing mice

Nanomedicine: Nanotechnology, Biology and Medicine

Mathilde Bausart

Giulia Rodella

Mathilde Dumont

Bernard Ucakar

Kevin Vanvarenberg

...

2023/6/1

Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel

Biomaterials Advances

Claire Gazaille

Elia Bozzato

Neda Madadian-Bozorg

Adélie Mellinger

Marion Sicot

...

2023/10/1

Stimuli‐Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood‐to‐Brain Trafficking and Tumor Targeting

Small

Cláudia Martins

Marco Araújo

Alessio Malfanti

Catarina Pacheco

Stuart J Smith

...

2023/6

Mismatch between bioluminescence imaging (BLI) and MRI when evaluating glioblastoma growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”

Cancers

Mathilde Bausart

Elia Bozzato

Nicolas Joudiou

Xanthippi Koutsoumpou

Bella Manshian

...

2023/3/22

Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma model

Drug Delivery and Translational Research

Alessio Malfanti

Mathilde Bausart

Kevin Vanvarenberg

Bernard Ucakar

Véronique Préat

2023/10

Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long …

Biomaterials

Giuseppina Catania

Giulia Rodella

Kevin Vanvarenberg

Véronique Préat

Alessio Malfanti

2023/3/1

Improvement of Lipid Detection in Mouse Brain and Human Uterine Tissue Sections Using In Situ Matrix Enhanced Secondary Ion Mass Spectrometry

Journal of the American Society for Mass Spectrometry

Thomas Daphnis

Benjamin Tomasetti

Vincent Delmez

Kevin Vanvarenberg

Véronique Préat

...

2023/9/15

Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation

European Journal of Pharmaceutics and Biopharmaceutics

Thibaut Fourniols

Valentina Maggio

Diana Rafael

Ariana Colaco

Elia García Vidal

...

2022/2/1

Barriers to the intestinal absorption of four insulin-loaded arginine-rich nanoparticles in human and rat

ACS nano

Patrik Lundquist

Georgiy Khodus

Zhigao Niu

Lungile Nomcebo Thwala

Fiona McCartney

...

2022/8/23

Immunotherapy for glioblastoma: the promise of combination strategies

Mathilde Bausart

Véronique Préat

Alessio Malfanti

2022/1/25

Combination of DNA vaccine and immune checkpoint blockades improves the immune response in an orthotopic unresectable glioblastoma model

Pharmaceutics

Mathilde Bausart

Kevin Vanvarenberg

Bernard Ucakar

Alessandra Lopes

Gaëlle Vandermeulen

...

2022/5/10

Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells

International journal of pharmaceutics

Elia Bozzato

Nikolaos Tsakiris

Adrien Paquot

Giulio G Muccioli

Chiara Bastiancich

...

2022/11/25

Design of bio-responsive hyaluronic acid–doxorubicin conjugates for the local treatment of glioblastoma

Pharmaceutics

Alessio Malfanti

Giuseppina Catania

Quentin Degros

Mingchao Wang

Mathilde Bausart

...

2022/1/5

Layer-by-layer nanoarchitectonics using protein–polyelectrolyte complexes toward a generalizable tool for protein surface immobilization

Langmuir

Cédric Vranckx

Laure Lambricht

Véronique Préat

Olivier Cornu

Christine Dupont-Gillain

...

2022/4/28

See List of Professors in Veronique Preat University(Université Catholique de Louvain)

Veronique Preat FAQs

What is Veronique Preat's h-index at Université Catholique de Louvain?

The h-index of Veronique Preat has been 60 since 2020 and 89 in total.

What are Veronique Preat's top articles?

The articles with the titles of

In situ administration of STING-activating hyaluronic acid conjugate primes anti-glioblastoma immune response

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

Multifunctional self-assembled peptide hydrogels for biomedical applications

Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma

Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI

Local delivery of doxorubicin prodrug via lipid nanocapsule–based hydrogel for the treatment of glioblastoma

Combination of local immunogenic cell death-inducing chemotherapy and DNA vaccine increases the survival of glioblastoma-bearing mice

Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel

...

are the top articles of Veronique Preat at Université Catholique de Louvain.

What are Veronique Preat's research interests?

The research interests of Veronique Preat are: Drug delivery, nanomedicines

What is Veronique Preat's total number of citations?

Veronique Preat has 34,305 citations in total.